Skip to main content


New Thematic Series: Obstructive Sleep Apnoea Syndrome

© © BVDC / Fotolia

Obstructive sleep apnea syndrome (OSAS) is an an underdiagnosed chronic disease characterized by recurrent episodes of apneas and hypopneas during sleep, associated with repetitive episodes of intermittent hypoxemia, intrathoracic pressure changes, arousals, and excessive daytime sleepiness.  OSAS is considered as risk factor for cancer. Patients with untreated OSAS are at significantly increased risk of cardiovascular, metabolic, neurocognitive disease and motor vehicle accidents (MVAs). The European Commission recommended mandatory testing for OSAS, before a driver's license is granted or renewed.

This collection provides the newest research, comprehensive background information and up-to-date information on obstructive sleep apnea syndrome. 

Call for papers: If you wish to submit your manuscript on obstructive sleep apnea syndrome (OSAS), please follow the instructions and submit your manuscript in Editorial Manager. Please select the thematic series upon submission. 


Aims and scope

Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP). The journal publishes on all aspects of respiratory medicine and related fields, with a particular focus on interdisciplinary and translational research.

The interdisciplinary nature of the journal provides a unique opportunity for researchers, clinicians and healthcare professionals across specialties to collaborate and exchange information. The journal provides a high visibility platform for the publication and dissemination of top quality original scientific articles, reviews and important position papers documenting clinical and experimental advances.

Given the journal’s interdisciplinary character, the target readership is wider than respiratory medicine, embracing numerous related disciplines (allergology, immunology, internal medicine, geriatrics, infectious diseases, intensive care, etc) and health professionals.

Latest supplement

New Content ItemThe best abstracts of the 2nd World Bronchiectasis Conference have been published in Multidisciplinary Respiratory Medicine as part of a special issue on Bronchiectasis.

You can read the supplement here.

Discounts for BioMed Central members

BioMed Central has a total of 522 Members across 56 countries, including 14 Italian institutions. Members can benefit from discounted or waived article processing charges (APCs) when publishing in Multidisciplinary Respiratory Medicine. Click here to find out more about our member institutions.

Sign up to receive article alerts

Multidisciplinary Respiratory Medicine is published continuously online-only and so we encourage you to sign up to receive free email alerts to keep up to date with all of the latest research by registering here.

Featured review: Recent advances in capsule-based dry powder inhaler technology

Pulmonary drug delivery is currently the focus of accelerated research and development because of the potential to produce maximum therapeutic benefit to patients by directly targeting drug to the site of pathology in the lungs. Among the available delivery options, the dry powder inhaler (DPI) is the preferred device for the treatment of an increasingly diverse range of diseases. This article reviews recent advances in capsule-based DPI technology and the introduction of the ‘disposable’ DPI device.

Read the article

Featured article: Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice

The intratracheal instillation of bleomycin in mice induces early damage to alveolar epithelial cells and development of inflammation followed by fibrotic tissue changes. Histopathology is the gold standard for assessing lung fibrosis in rodents, however it precludes repeated and longitudinal measurements of disease progression. This study investigates the use of the Micro-CT technique to allow the evaluation of disease onset and progression at different time-points in the mouse bleomycin model of lung fibrosis. 

Read the article

Editors' profiles

Francesco Blasi,  Editor-in-Chief

Francesco Blasi, MD, FERS is a Professor of Respiratory Medicine at the Department of Pathophysiology and Transplantation of the University of Milan. Additionally, he is Head of the Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center IRCCS Fondazione Cà Granda Ospedale Maggiore in Milan . Prof Blasi is a former President of European Respiratory Society (ERS) 2012-13 and past President of the Italian Respiratory Society (SIP/IRS). He is currently serving as President of the Italian Respiratory Society Research Center  2017-2018. Prof Blasi has published more than 300 papers in International Journals. His research interests include pneumonia, COPD, bronchiectasis, cystic fibrosis and lung transplantation.

Claudio Sanguinetti, Editor-in-Chief

Dr Claudio Sanguinetti is a senior consultant in respiratory medicine at the Quisisana Clinical Center in Rome, Italy. He has had many teaching appointments in respiratory medicine at Ancona University, and now teaches in a degree course of the Catholic University in Rome.


Official journal of

Annual Journal Metrics